Clinical Trial Update: Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation study assessing cyclophosphamide in HIV-infected individuals on HAART prior to SB-728-T therapy; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• SB-728-T (not provided)

Snippet

Sponsor: Sangamo Therapeutics | Conditions: HIV | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-21